Flerie Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Professionals
-
5

- Investments
-
53
- Portfolio
-
31
- Exits
-
6

Flerie General Information
Company Description
Founded in 2011, Flerie Invest is a venture capital firm based in Stockholm, Sweden. The firm seeks to invest in early-stage companies in the healthcare sector. The firm prefers to invest across Europe, the United States, the United Kingdom, and Israel.
Business Details
Website
www.flerie.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Skeppsbron 16
- 111 30 Stockholm
- Sweden
Flerie Investments & Acquisitions (53)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Toleranzia | 25-Mar-2025 | Secondary Transaction - Private | Drug Discovery | Profitable | ||
Vitara (Healthcare Services) | 19-Nov-2024 | Other Healthcare Services | Pre-Clinical Trials | |||
Xspray Pharma | 29-Jul-2024 | Drug Discovery | Generating Revenue | |||
InDex Pharmaceuticals | 10-Jun-2024 | Drug Discovery | Profitable | |||
AnaCardio | 17-Jan-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
Frontier Biosolutions | 16-Oct-2023 | Holding Companies | ||||
Coriolis Pharma | 10-Oct-2023 | Pharmaceuticals | Generating Revenue | |||
Synerkine Pharma | 03-Oct-2023 | Drug Discovery | Pre-Clinical Trials | |||
Mendus | 08-Jun-2023 | PIPE | Drug Discovery | Profitable | ||
Empros Pharma | 03-May-2023 | Later Stage VC | Drug Discovery | Clinical Trials - General |
Flerie Exits (6)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
A3P Biomedical | 06-Mar-2025 | Secondary Transaction - Private | |
XNK Therapeutics | 09-Apr-2024 | ||
QuTEM | 20-Nov-2023 | ||
Cobra Biologics | 21-Jan-2020 | ||
Cormorant Pharmaceuticals | 05-Jul-2016 | Merger/Acquisition | |
Wilson Therapeutics | 25-May-2016 | IPO |
Flerie Investments by Industry, Year, and Region
Flerie Co-Investors (61)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
IP Group | 1 |
![]() |
![]() |
||
Industrifonden |
![]() |
![]() |
|||
Khosla Ventures |
![]() |
![]() |
|||
Kohlberg Kravis Roberts |
![]() |
![]() |
|||
Novo Holdings |
![]() |
![]() |
Flerie Affiliates
Subsidiaries (3)
Name | Industry | Location | Year Founded |
---|---|---|---|
Empros Pharma | Solna, Sweden | 2013 | |
Toleranzia | Gothenburg, Sweden | 2011 | |
Xintela | Lund, Sweden | 2009 |
Flerie FAQs
-
What is Flerie?
Founded in 2011, Flerie Invest is a venture capital firm based in Stockholm, Sweden.
-
When was Flerie founded?
Flerie was founded in 2011.
-
Where is Flerie headquartered?
Flerie is headquartered in Stockholm, Sweden.
-
What is Flerie's total asset value?
Flerie has around
in total assets under management. -
How many investments has Flerie made?
Flerie has made 53 investments.
-
What has Flerie invested in?
Flerie has made numerous investments in companies like Toleranzia, Vitara (Healthcare Services), and Xspray Pharma within the Drug Discovery and Healthcare Services industries.
-
What has Flerie invested in recently?
Flerie's latest investment was on 25-Mar-2025 in Toleranzia, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »